All In Biotech

Free tool

FAERS Monitor: Quzyttir

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 211415 or its brand name (Quzyttir, Cetirizine Hydrochloride). Reports on generic versions are filed under their own applications.

Reports

31,397

Serious

24,248

77% of reports

Hospitalization

9,666

Death reported

5,131

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective9,563
  • pain8,983
  • fatigue8,946
  • alopecia7,541
  • rheumatoid arthritis7,475
  • abdominal discomfort7,448
  • systemic lupus erythematosus7,162
  • pemphigus7,032
  • off label use6,781
  • rash6,691
  • glossodynia6,533
  • swelling6,091
  • hypersensitivity5,812
  • hand deformity5,687
  • infusion related reaction5,618

Reports by year received

View as table
YearReports
200419
200560
200620
200766
2008169
2009159
2010137
2011137
2012159
2013208
2014240
2015359
2016814
2017874
20181,009
20191,555
20202,155
20214,402
20224,406
20233,425
20244,299
20254,038
20262,687

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,022,762 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
pemphigusSignal7,032858.9830.62,640,874
hand deformitySignal5,687511.6495.11,643,608
glossodyniaSignal6,533275.6268.31,267,248
systemic lupus erythematosusSignal7,162169.1165.1956,768
infusion related reactionSignal5,61861.960.4309,213
rheumatoid arthritisSignal7,47547.146.2317,060
swellingSignal6,09146.645.5254,990
abdominal discomfortSignal7,44831.130.4208,828
alopeciaSignal7,54126.726.2181,128
hypersensitivitySignal5,81221.621.1111,690
rashSignal6,69110.410.257,334
painSignal8,9839.99.873,187
fatigueSignal8,9467.87.654,210
off label useSignal6,7815.25.123,951
drug ineffectiveSignal9,5634.94.831,329

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.